Leveraging innovations for real-world data collection

Innovative technologies are transforming real-world evidence (RWE) collection in healthcare. In this video, Shazia Hassan, Manager of Market Access and HEOR, explores how digital health platforms, wearables, and smart interventions reduce patient burden while providing valuable, real-time insights. By integrating these advancements with patient support programs, we can capture robust data to improve outcomes, enhance access to treatments, and strengthen healthcare decision-making.

Transcript of 'Leveraging innovations for real-world data collection'

 

How can innovations improve the way we collect and utilize RWE in healthcare? 

 

Patient support programs are a key source of generating real-world evidence, but how can we take it further?

There are opportunities to improve how we collect and use this data to better understand patient needs and treatment effectiveness.

A key challenge in doing this is balancing robust data collection with patient burden.

Traditional methods can be time-consuming and difficult for patients to engage with consistently.

So, how do we gather more data without overwhelming patients?

One way of doing this is by leveraging innovative technologies.

Digital health platforms, wearables, and smart interventions can transform how we collect data.

For instance, instead of just tracking prescription refills, imagine getting real-time insights on when patients take their medications or miss doses, all while reducing the burden on the patient.

When we integrate this data with patient support programs, we can capture even more valuable information in real time.

Improved data collection methods with innovative technologies can provide insights for patients and programs.

This also means providing compelling evidence to decision-makers, such as healthcare providers, payers and health technology assessment organizations on the real-world value of therapies.

So, what does the future hold for RWE?

It’s all about innovation and finding better ways to collect and use real-world data.

By doing so, we can boost patient outcomes, improve access to effective treatments, and strengthen healthcare decisions.

The information provided in this piece does not constitute legal or medical advice. Innomar Strategies Inc. and its parent Cencora, Inc. strongly encourage the audience to review available information related to the topics discussed to rely on their own experience and expertise in making decisions related thereto. Further, the contents of this piece are owned by Innomar Strategies, and reproduction is not permitted without the consent of Innomar Strategies.